tetradecanoylphorbol acetate has been researched along with 4,5-dihydro-6-(4-(imidazol-1-yl)phenyl)-5-methyl-3(2h)-pyridazinone in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bansbach, CC; Caccese, RG; Heaslip, RJ; Lewis, GM | 1 |
1 other study(ies) available for tetradecanoylphorbol acetate and 4,5-dihydro-6-(4-(imidazol-1-yl)phenyl)-5-methyl-3(2h)-pyridazinone
| Article | Year |
|---|---|
Effects of rolipram and CI-930 on IL-2 mRNA transcription in human Jurkat cells.
Topics: Animals; Cell Survival; Humans; Interleukin-2; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Phosphodiesterase Inhibitors; Pyridazines; Pyrrolidinones; RNA, Messenger; Rolipram; Spleen; T-Lymphocytes; Tetradecanoylphorbol Acetate; Transcription, Genetic; Tumor Cells, Cultured | 1993 |